Chronic stress-induced alterations in mouse colonic 5-HT and defecation responses are strain dependent

Stress

Volumn 15, Issue 2, 2012, Pages 218-226

  Julio Pieper, Marcela ^a   O'Mahony, Cliona M ^a   Clarke, Gerard ^a,b   Bravo, Javier A ^a   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Anxiety; Braingut axis; Depression; Diarrhoea; Irritable bowel syndrome; Serotonin

Indexed keywords

CORTICOSTERONE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CHRONIC STRESS; COLON; CONTROLLED STUDY; COPING BEHAVIOR; CORTICOSTERONE BLOOD LEVEL; DEFECATION; DIARRHEA; HORMONE SENSITIVITY; IMMOBILIZATION STRESS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLON; CORTICOSTERONE; DEFECATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RESTRAINT, PHYSICAL; SEROTONIN; SPECIES SPECIFICITY; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84856207917     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2011.607524     Document Type: Article

References (50)

1. Belzung C, Griebel G. 2001. Measuring normal and pathological anxiety-like behaviour in mice: A review. Behav Brain Res 125(1-2):141-149. (Pubitemid 33000452)
2. Bertrand PP, Bertrand RL. 2010. Serotonin release and uptake in the gastrointestinal tract. Auton Neurosci 153(1-2):47-57.
3. Bowers SL, Bilbo SD, Dhabhar FS, Nelson RJ. 2008. Stressorspecific alterations in corticosterone and immune responses in mice. Brain Behav Immun 22(1):105-113. (Pubitemid 350216366)
4. Brinks V, van der Mark M, de Kloet R, Oitzl M. 2007. Emotion and cognition in high and low stress sensitive mouse strains: A combined neuroendocrine and behavioral study in BALB/c and C57BL/6J mice. Front Behav Neurosci 1(8):1-12.
5. Browne, CA, Clarke, G, Dinan, T, Cryan, JF. 2011 Differential stress-induced alterations in tryptophan hydroxylase activity and serotonin turnover in two inbred mouse strains. Neuropharmacology 60(4):683-691.
6. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Gohlmann H, van den Wyngaert I, Coulie B. 2007. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132(1):17-25. (Pubitemid 46108754)
7. Clarke G, Quigley EM, Cryan JF, Dinan TG. 2009. Irritable bowel syndrome: Towards biomarker identification. Trends Mol Med 15(10):478-489.
8. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL. 2004. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126(7):1657-1664. (Pubitemid 38736329)
9. Colucci R, Blandizzi C, Bellini M, Ghisu N, Tonini M, Del Tacca M. 2008. The genetics of the serotonin transporter and irritable bowel syndrome. Trends Mol Med 14(7):295-304.
10. Cryan JF, Holmes A. 2005. The ascent of mouse: Advances in modelling human depression and anxiety. Nat Rev Drug Discov 4(9):775-790. (Pubitemid 43090498)
11. Cryan JF, Leonard BE. 2000. 5-HT1A and beyond: The role of serotonin and its receptors in depression and the antidepressant response. Hum Psychopharmacol 15(2):113-135. (Pubitemid 30199285)
12. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. 2005. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3(4):349-357. (Pubitemid 40488343)
13. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. 2009. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis. Gut 58(3):367-378.
14. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. 2010. Mood and gut feelings. Brain Behav Immun 24(1):9-16.
15. Govindarajan A, Rao BS, NairD, Trinh M, Mawjee N, Tonegawa S, Chattarji S. 2006. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103(35):13208-13213. (Pubitemid 44338941)
16. Griebel G, Belzung C, Perrault G, Sanger DJ. 2000. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 148(2):164-170. (Pubitemid 30104138)
17. Gros DF, AntonyMM, McCabe RE, Swinson RP. 2009. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord 23(2): 290-296.
18. Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K. 2008. Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. Eur J Pharmacol 587(1-3): 281-284.
19. Jacobson LH, Cryan JF. 2007. Feeling strained? Influence of genetic background on depression-related behavior in mice: A review. Behav Genet 37(1):171-213. (Pubitemid 46150858)
20. Jun S, Kohen R, Cain KC, Jarrett ME, Heitkemper MM. 2011. Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 23(3): 233-239, e116.
21. Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M. 1993. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. J Pharmacol Exp Ther 266(1):74-80. (Pubitemid 23315630)
22. Kapeller J, Houghton LA, Monnikes H, Walstab J, Moller D, Bonisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N, Fischer C, Whorwell PJ, AtkinsonW, Fell C, Buchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B. 2008. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 17(19):2967-2977.
23. Kawano K, Mori T, Fu L, Ito T, Niisato T, Yoshida S, Shiokawa S, Sato Y, Murakami H, Shishikura T. 2005. Comparison between partial agonist (ME3412) and antagonist (alosetron) of 5-hydroxytryptamine 3 receptor on gastrointestinal function. Neurogastroenterol Motil 17(2):290-301. (Pubitemid 40476691)
24. Kulikov AV, Osipova DV, Naumenko VS, Popova NK. 2005. Association between Tph2 gene polymorphism, brain tryptophan hydroxylase activity and aggressiveness in mouse strains. Genes Brain Behav 4(8):482-485. (Pubitemid 41689393)
25. Larauche M, Gourcerol G, Million M, Adelson DW, Taché Y. 2010. Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: Influence of surgery and postoperative single housing on visceromotor responses. Stress 13(4):343-354.
26. Larsson MH, Miketa A, Martinez V. 2009. Lack of interaction between psychological stress and DSS-induced colitis affecting colonic sensitivity during colorectal distension in mice. Stress 12(5):434-444.
27. Matthes S, Mosienko V, Bashammakh S, Alenina N, Bader M. 2010. Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology 85(2):95-109.
28. Melgar S, Engstrom K, Jagervall A, Martinez V. 2008. Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice. Stress 11(5):348-362.
29. Miwa J, Echizen H, Matsueda K, Umeda N. 2001. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion 63(3):188-194. (Pubitemid 32429734)
30. Mussell M, Kroenke K, Spitzer RL, Williams JB, Herzog W, Lowe B. 2008. Gastrointestinal symptoms in primary care: Prevalence and association with depression and anxiety. J Psychosom Res 64(6):605-612.
31. Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T. 2007. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol 292(4):G1037-G1044. (Pubitemid 46557783)
32. Nakamura K, Sugawara Y, Sawabe K, Ohashi A, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Nishimura H, Hasegawa H, Hirose S. 2006. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. J Neurosci 26(2):530-534. (Pubitemid 43237117)
33. O'Mahony S, Chua AS, Quigley EM, Clarke G, Shanahan F, Keeling PW, Dinan TG. 2008. Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. Neurogastroenterol Motil 20(6): 680-688. (Pubitemid 351678611)
34. O'Mahony CM, Clarke G, Gibney SM, Dinan T, Cryan JF. 2011. Strain differences in the neurochemical response to chronic restraint stress in the rat: Relevance to depression. Pharmacol Biochem Behav, in press.
35. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG. 2009. Early life stress alters behavior, immunity, and microbiota in rats: Implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65(3):263-267.
36. O'Mahony CM, Sweeney FF, Daly E, Dinan TG, Cryan JF. 2010. Restraint stress-induced brain activation patterns in two strains of mice differing in their anxiety behaviour. Behav Brain Res 213(2):148-154.
37. Owens MJ, Nemeroff CB. 1994. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40(2):288-295. (Pubitemid 24072594)
38. Quigley EM. 2006. Changing face of irritable bowel syndrome. World J Gastroenterol 12(1):1-5. (Pubitemid 43126074)
39. Robinson OJ, Cools R, Crockett MJ, Sahakian BJ. 2010. Mood state moderates the role of serotonin in cognitive biases. J Psychopharmacol 24(4):573-583.
40. Sanger GJ. 2008. 5-hydroxytryptamine and the gastrointestinal tract: Where next? Trends Pharmacol Sci 29(9):465-471.
41. Savelieva KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E, Lanthorn TH. 2008. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 3(10):e3301.
42. Savignac HM, Dinan TG, Cryan JF. 2011a. Resistance to early-life stress in mice: Effects of genetic background and stress duration. Front Behav Neurosci 5:13.
43. Savignac HM, Finger BC, Pizzo RC, O'Leary OF, Dinan TG, Cryan JF. 2011b. Increased sensitivity to the effects of chronic social defeat stress in an innately anxious mouse strain. Neuroscience. 2011 May 27. [Epub ahead of print].
44. Spiller R. 2002. Serotonergic modulating drugs for functional gastrointestinal diseases. Br J Clin Pharmacol 54(1):11-20. (Pubitemid 36124749)
45. Spiller R. 2008. Serotonergic agents and the irritable bowel syndrome: What goes wrong? Curr Opin Pharmacol 8(6): 709-714.
46. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. 2000. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47(6):804-811.
47. Taché Y, Martinez V, Million M, Wang L. 2001. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: Role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 280(2):G173-G177.
48. Tsukamoto K, Ariga H, Mantyh C, Pappas TN, Yanagi H, Yamamura T, Takahashi T. 2007. Luminally released serotonin stimulates colonic motility and accelerates colonic transit in rats. Am J Physiol Regul Integr Comp Physiol 293(1):R64-R69. (Pubitemid 47092163)
49. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299(5603):76. (Pubitemid 36042402)
50. Zhang X, Beaulieu JM, SotnikovaTD, Gainetdinov RR, CaronMG. 2004. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305(5681):217. (Pubitemid 38886729)